peg/ppg-98/67 copolymer
oxirane, methyl, polymer with oxirane (98 mol EO, 67 mol PO average molar ratio)
Identification
| Name | peg/ppg-98/67 copolymer |
| IUPAC | 2-methyloxirane; oxirane (98;67) |
| CAS Number | 9003-11-6 |
| FDA UNII | Search |
| Molecular Formula | (C3 H6 O.C2 H4 O)x- |
Regulatory
| FDA/DG SANTE Petitions, Reviews, Notices | FCN 1020 |
| FDA Mainterm (SATF) | 9003-11-6 ; ETHYLENE OXIDE/PROPYLENE OXIDE COPOLYMER |
| FDA Regulation | FDA PART 172 -- FOOD ADDITIVES PERMITTED FOR DIRECT ADDITION TO FOOD FOR HUMAN CONSUMPTION |
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Boiling Point | 275.31 °C. @ 760.00 mm Hg (est) |
| Vapor Pressure | 0.001000 mmHg @ 25.00 °C. (est) |
| Flash Point | 249.00 °F. TCC ( 120.30 °C. ) (est) |
| logP (o/w) | -1.293 (est) |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | surfactants |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | intravenous-mouse LD50 175 mg/kg |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | inhalation-rat LC50 320 mg/m3/4H |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | emulsifiers and foaming agents |
| Recommendation for peg/ppg-98/67 copolymer usage levels up to | not for fragrance use. |
| Recommendation for peg/ppg-98/67 copolymer flavor usage levels up to | not for flavor use. |
BOC Sciences
Best of Chemicals Supplier
Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...
Penta International Corporation
Chemistry innovation
At Penta, our products and services help businesses do business better.
Potential Uses
Natural Occurrence
Synonyms
methyl oxirane polymer with oxirane (98;67)
2-
methyloxirane; oxirane (98;67)
oxirane, methyl, polymer with oxirane (98 mol EO, 67 mol PO average molar ratio)
pluracare F 127
pluronic P-123
poloxamer 407
PubMed:
Effect of interfacial composition on uptake of curcumin-piperine mixtures in oil in water emulsions by Caco-2 cells.
PubMed:
Simvastatin treatment upregulates intestinal lipid secretion pathways in a rodent model of the metabolic syndrome.
PubMed:
Mechanical, rheological and release behaviors of a poloxamer 407/ poloxamer 188/carbopol 940 thermosensitive composite hydrogel.
PubMed:
Antidiabetic activity and molecular docking of fructooligosaccharides produced by Aureobasidium pullulans in poloxamer-407-induced T2DM rats.
PubMed:
Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
PubMed:
Regulatory function of a malleable protein matrix as a novel fermented whey product on features defining the metabolic syndrome.
PubMed:
Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats.
PubMed:
Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models.
PubMed:
The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins.
PubMed:
Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats.